The short version
- •ECT uses a brief, controlled electrical stimulus to induce a short therapeutic seizure under general anesthesia — and it is the single most effective treatment for severe and treatment-resistant depression.
- •Modern ECT bears no resemblance to its frightening media image: it is done under anesthesia with a muscle relaxant, the patient is asleep and still, and it is a routine, safe medical procedure.
- •It is reserved for severe, treatment-resistant, psychotic, or life-threatening depression (including acute suicidality and catatonia), where its speed and effectiveness can be life-saving.
- •The main side effect is memory disturbance — usually temporary, around the treatment period — which modern techniques (e.g., right unilateral electrode placement) have substantially reduced.
- •A course is typically a series of treatments (e.g., 2-3 times weekly for several weeks), often followed by maintenance.
- •ECT and ketamine both treat severe/treatment-resistant depression rapidly; ECT remains the most effective option for the most severe cases, while ketamine is a less intensive, at-home option for many treatment-resistant patients.
What it is
Electroconvulsive therapy is a medical procedure in which a brief, carefully controlled electrical current is applied to the scalp to induce a short, generalized seizure while the patient is under general anesthesia with a muscle relaxant. Despite a fearsome cultural reputation shaped by mid-20th-century practice and film, modern ECT is a safe, routine, and humane procedure: the patient is fully asleep, does not move or feel pain, and the seizure is therapeutic and closely monitored. It is the most effective treatment available for severe major depression — particularly treatment-resistant depression, depression with psychotic features, depression with acute suicide risk, catatonia, and severe bipolar depression — with response rates that exceed those of any medication in these populations and a rapid onset that can be life-saving. ECT is delivered as a course (commonly two to three sessions per week over several weeks), frequently followed by maintenance ECT or medication to prevent relapse. Electrode placement and dosing (e.g., right unilateral placement) are chosen to balance efficacy with minimizing cognitive side effects.
What it helps with
Treatment-resistant depression
The most effective option when multiple medications and therapies have failed.
Highly effective for severe and psychotic depression in particular; not used for mild-to-moderate cases.
Suicidal thoughts
Its speed makes it valuable when rapid response is life-saving, within a hospital or crisis context.
Bipolar depression
Among the most effective treatments for severe bipolar depression and for catatonia.
What to expect
Under anesthesia
Each treatment is brief, done under general anesthesia with a muscle relaxant; you are asleep and feel nothing.
A course of treatments
Commonly 2-3 sessions per week over several weeks, often followed by maintenance.
Recovery
Short-term confusion after each session that clears; arrange not to drive on treatment days.
Memory effects
Some memory disturbance around the treatment period, usually temporary and reduced by modern techniques.
The evidence
ECT has the strongest efficacy evidence of any treatment for severe depression. A landmark systematic review and meta-analysis (UK ECT Review Group 2003, The Lancet) found ECT significantly more effective than pharmacotherapy and than sham (simulated) ECT for depressive disorders. Decades of subsequent evidence confirm it as the most effective treatment for treatment-resistant, psychotic, and severe depression, with modern techniques markedly reducing cognitive side effects. It is recommended in guidelines for the most severe and treatment-resistant presentations.
How it pairs with ketamine
ECT and ketamine are the two most prominent rapid-acting options for severe, treatment-resistant depression, and both act outside the standard antidepressant mechanism. ECT remains the most effective treatment for the most severe cases — psychotic depression, catatonia, acute life-threatening suicidality — and is delivered in a hospital or clinic setting under anesthesia. Ketamine is far less intensive: no anesthesia, no induced seizure, no memory effects, and (in Tovani's model) delivered at home, making it suitable for many treatment-resistant patients who don't require ECT-level intervention. They occupy different points on the severity spectrum; for the most severe or emergent cases, ECT is the gold standard, and a clinician helps determine which fits. If you are in crisis, call or text 988.
Frequently asked
Is ECT safe? Isn't it barbaric?
Modern ECT is a safe, routine medical procedure done under general anesthesia with a muscle relaxant — the patient is asleep, still, and feels nothing. Its frightening reputation comes from mid-20th-century practice and movies, not how it is done today. It is the most effective treatment available for severe depression.
When is ECT used?
It is reserved for severe, treatment-resistant, psychotic, or life-threatening depression — including acute suicidality, catatonia, and severe bipolar depression — where its speed and effectiveness can be life-saving. It is not a first-line treatment for mild or moderate depression.
Will ECT affect my memory?
Some memory disturbance around the treatment period is the main side effect; it is usually temporary, and modern techniques (like right unilateral electrode placement) have substantially reduced it. Permanent gaps are uncommon. Your team weighs efficacy against cognitive effects in choosing the technique.
ECT or ketamine?
They are different tools. ECT is the most effective option for the most severe cases (psychotic depression, catatonia, emergent suicidality), done under anesthesia in a clinic. Ketamine is much less intensive — no anesthesia or seizure, done at home in Tovani's model — and fits many treatment-resistant patients who don't need ECT-level care. A clinician helps determine the right level.
References
- UK ECT Review Group 2003, The Lancet. Landmark systematic review and meta-analysis finding ECT significantly more effective than pharmacotherapy and sham for depressive disorders. PMID 12642045